- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: patent blue V dye
Total 168 results
-
Oslo University HospitalActive, not recruitingDrug Effect | Adverse Drug Effect | Heart ArrhythmiaNorway
-
Novartis VaccinesCompletedMeningitis, MeningococcalUnited States, Argentina, Colombia
-
Yale UniversityTerminatedDe Novo Autoimmune Hepatitis
-
University Hospital, Clermont-FerrandCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedThyroid Cancer | Papillary MicrocarcinomaUnited States
-
University of BirminghamCancer Research UK; GenmabRecruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited Kingdom
-
St. Anna KinderkrebsforschungUnknownLymphoblastic Leukemia, Acute, Childhood;Israel, Austria, Czech Republic, Denmark, France, Italy, Netherlands, Poland, Slovakia, Sweden, Turkey
-
Stanford UniversityNational Comprehensive Cancer NetworkCompletedKidney Neoplasms | Carcinoma, Renal Cell | Kidney (Renal Cell) CancerUnited States
-
Semmelweis UniversityRecruitingPremature Birth | Respiratory Failure | Apnea of PrematurityHungary
-
Sultan Qaboos UniversityNot yet recruitingPanic Disorder
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Shanghai Jiao Tong University School of MedicineCompleted
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAnal Canal Cloacogenic Carcinoma | Stage III Anal Cancer AJCC v8 | Anal Margin Squamous Cell Carcinoma | Stage IIB Anal Cancer AJCC v8 | Anal Basaloid Squamous Cell CarcinomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompletedDelirium | QT-prolongationBelgium
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States